Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,966.85
    +34.87 (+0.44%)
     
  • Bitcoin USD

    70,691.24
    +1,890.28 (+2.75%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,252.39
    +3.90 (+0.07%)
     
  • Dow

    39,785.72
    +25.64 (+0.06%)
     
  • Nasdaq

    16,387.12
    -12.40 (-0.08%)
     
  • Gold

    2,234.30
    +21.60 (+0.98%)
     
  • Crude Oil

    82.56
    +1.21 (+1.49%)
     
  • 10-Yr Bond

    4.1870
    -0.0090 (-0.21%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?

Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?

One welcome sign with the COVID-19 pandemic is how many companies, both large and small, have scrambled to develop diagnostic tests, antiviral treatments, and vaccines. Sure, these companies are in business to make money and have a profit motive behind their efforts. Inovio Pharmaceuticals (NASDAQ: INO) ranks as one of the leaders in the race to develop a COVID-19 vaccine.